CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to PHVS

Deucrictibant

Phase 3
Pharvaris N.V. (PHVS)

Phase 3

Development Phase

2

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jun '27
PHVSPhase 3

Deucrictibant Phase 3 Est. Readout (CREAATE)

Deucrictibant
Jun 2027~
CT.gov
00%
6mo
PHVSPDUFA
Phase 3

FDA PDUFA Date deucrictibant (immediate-release, 20 mg) (standard)

Deucrictibant
Apr 23
SEC
00%
Competitive Landscape

1 competitor in Hereditary Angioedema

View Full Landscape
Drug Information

Target Indication

Hereditary Angioedema

Clinical Trial

NCT04618211

Last updated: 6/27/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.